Abacus Planning Group »

Prime Medicine shares owned by Abacus Planning Group

Quarter-by-quarter ownership of Prime Medicine (PRME) shares owned by Abacus Planning Group from 13F filings

Historical chart of Abacus Planning Group investment in Prime Medicine

Tip: Access up to 7 years of quarterly data

All positions including Prime Medicine held by Abacus Planning Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Prime Medicine by Abacus Planning Group

Quarter filed Position value Share count Share price at filing
2025-12-31 $87k 25k 3.47
2025-09-30 $140k 25k 5.54

More positions owned by Abacus Planning Group

Etf Ser Solutions Distillate Us (DSTL)
Vanguard Index Fds Total Stk Mkt (VTI)
Ishares Tr 0-5 Yr Tips Etf (STIP)
Vanguard Index Fds Sm Cp Val Etf (VBR)
Vanguard Star Fds Vg Tl Intl Stk F (VXUS)
Vanguard Tax-managed Fds Van Ftse Dev Mkt (VEA)
J P Morgan Exchange Traded F Mortgage Backed (JMTG)
Amazon (AMZN)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Union Pacific Corporation (UNP)
Apple (AAPL)
Dimensional Etf Trust World Equity Etf (DFAW)
Dimensional Etf Trust Intl Small Cap E (DFIS)
Vanguard Index Fds Value Etf (VTV)
Microsoft Corporation (MSFT)

View all positions for Abacus Planning Group

Top funds holding Prime Medicine

Alphabet
BlackRock
Vanguard Group
T. Rowe Price Investment Management
ARK Investment Management
State Street Corporation
Sumitomo Mitsui Trust Holdings
Nikko Asset Management Americas
Casdin Capital
Woodline Partners
RA Capital Management
FMR
Geode Capital Management
UBS Group
D. E. Shaw & Co

View all funds holding Prime Medicine